Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 688
Selected: 0
NCT IDTitle
NCT01129882An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia
NCT02006654Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
NCT01074294Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
NCT02094469Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina
NCT05593029A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
NCT04838639Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects
NCT03510663Phase I Study of OPC-61815
NCT02174835A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers
NCT00731549Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT01787747Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers
NCT00520650Health Evaluation of Abilify Long-term Therapy
NCT00234104A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)
NCT02219009Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
NCT00082199Study of Aripiprazole in Subjects With Alcoholism
NCT00934232Busulfan in Multiple Myeloma
NCT06212804A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult Participants
NCT06575426A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
NCT00202020Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke
NCT02964273Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
NCT00325689Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.
NCT01862640A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
NCT02442674A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
NCT00036361Broad Effectiveness: Study With Aripiprazole
NCT07465731A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine
NCT02012959Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
NCT04150172To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers
NCT00448357Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
NCT02087007A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
NCT02755753A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis
NCT03386851Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder
NCT07075328A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma
NCT01114828A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edema
NCT01702181A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
NCT01416441Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT02250170Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor
NCT03303105Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
NCT02225067Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring
NCT01284959Different Safety Profile of Risperidone and Paliperidone Extended-release
NCT00763490Trial Of Double Umbilical Cord Blood Transplantation
NCT03872596Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
NCT01737931A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject
NCT07225712A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
NCT03568500A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT02446132Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT02183792Aquaresis Utility for Hyponatremic Acute Heart Failure Study
NCT03172871Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia
NCT03724942Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT05015673This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.
NCT04100096A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
NCT00657176An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors